Literature DB >> 12081717

Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients.

G Kumaramanickavel1, S Sripriya, R N Vellanki, N K Upadyay, S S Badrinath, V Rajendran, B Sukumar, V L Ramprasad, T Sharma.   

Abstract

Nitric oxide, a signal transduction molecule, when modulated causes various diseases including diabetic retinopathy. In diabetes, allelic polymorphism of the inducible nitric oxide synthase (iNOS) gene is associated with retinopathy in the Northern Irish population. In the present study we investigated the Asian Indian population. One hundred and ninety-nine unrelated Asian Indian patients with 15 or more years of type 2 diabetes were divided into two groups: (a) diabetic retinopathy (DR) and (b) diabetic nonretinopathy (DNR) subjects. In these groups the pentanucleotide microsatellite repeat located 2.5 kb upstream of the transcription start site of the iNOS gene was amplified by polymerase chain reaction and analyzed. Eleven alleles, 175-225 bp, were identified. Allele 210 bp was significantly associated with retinopathy (p = 0.044). Individuals carrying this allele had twice the risk of developing retinopathy compared with those who did not carry this allele [odds ratio (OR) - 2.03; 95% CI 0.96-4.35]. Alleles 200 and 220 bp were also significantly associated with no retinopathy and no serious retinopathy complications, respectively. In the Asian Indian population, allele 210 bp of the iNOS gene is a high-risk allele for developing retinopathy and alleles 200 and 220 bp protect an individual from developing retinopathy or its complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081717     DOI: 10.1046/j.0009-9163.2002.00251.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Current state of care for diabetic retinopathy in India.

Authors:  Kim Ramasamy; Rajiv Raman; Manish Tandon
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

2.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

3.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response.

Authors:  Rajiv Raman; Aditi Gupta
Journal:  Diabetol Metab Syndr       Date:  2010-03-25       Impact factor: 3.320

4.  TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.

Authors:  B Cameron Carr; Caitlyn E Emigh; Lea D Bennett; Andrew D Pansick; David G Birch; Chan Nguyen
Journal:  Retina       Date:  2017-01       Impact factor: 4.256

5.  The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management.

Authors:  Mihai Dumitru Porojan; Andreea Cătană; Radu A Popp; Dan L Dumitrascu; Cornelia Bala
Journal:  Ther Clin Risk Manag       Date:  2015-11-27       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.